David Apelian
2014 - Achillion Pharmaceuticals
In 2014, David Apelian earned a total compensation of $2.5M as Executive Vice President and Chief Medical Officer at Achillion Pharmaceuticals, a 15% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $212,212 |
|---|---|
| Option Awards | $1,791,457 |
| Salary | $457,600 |
| Other | $32,016 |
| Total | $2,493,285 |
Apelian received $1.8M in option awards, accounting for 72% of the total pay in 2014.
Apelian also received $212.2K in non-equity incentive plan, $457.6K in salary and $32K in other compensation.
Rankings
In 2014, David Apelian's compensation ranked 3,651st out of 13,032 executives tracked by ExecPay. In other words, Apelian earned more than 72.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,651 out of 13,032 | 72nd |
Division Manufacturing | 1,289 out of 4,966 | 74th |
Major group Chemicals And Allied Products | 419 out of 1,686 | 75th |
Industry group Drugs | 324 out of 1,365 | 76th |
Industry Pharmaceutical Preparations | 262 out of 1,043 | 75th |
Source: SEC filing on April 17, 2017.
Apelian's colleagues
We found four more compensation records of executives who worked with David Apelian at Achillion Pharmaceuticals in 2014.
2014
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
2014
Joseph Truitt
Achillion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2014
Mary Fenton
Achillion Pharmaceuticals
Chief Financial Officer
2014
Gautam Shah
Achillion Pharmaceuticals